Published in Arch Biochem Biophys on November 01, 1969
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med (1989) 4.19
Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest (1984) 2.88
Production of K99 antigen by enterotoxigenic Escherichia coli strains of antigen groups o8, o9, o20, and o101 grown at different conditions. Infect Immun (1980) 2.83
Cloning, mapping and expression of the genetic determinant that encodes for the K88ab antigen. Nucleic Acids Res (1979) 2.80
Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect Immun (1987) 2.50
N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol (1998) 2.49
Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol (1990) 2.39
A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J Clin Invest (1982) 2.33
Isolation and nucleotide sequence of the methanol dehydrogenase structural gene from Paracoccus denitrificans. J Bacteriol (1987) 1.96
A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis. J Cell Biol (1989) 1.95
Development and application of an enzyme linked immunosorbent assay for Clostridium perfringens type A enterotoxin. J Clin Pathol (1985) 1.85
Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol (1985) 1.76
Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A (1989) 1.74
Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest (1989) 1.70
Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest (1991) 1.68
Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin m antibodies. J Clin Microbiol (1983) 1.67
Biosynthesis of the K99 surface antigen is repressed by alanine. Infect Immun (1980) 1.63
Immunochemical analysis of cartilage proteoglycans. Antigenic determinants of substructures. Biochem J (1979) 1.61
Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61
Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications. J Clin Invest (1979) 1.58
Diagnosis of systemic candidiasis by latex agglutination for serum antigen. J Clin Microbiol (1985) 1.56
Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun (1983) 1.51
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor. J Exp Med (1985) 1.47
Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigen. J Clin Invest (1988) 1.45
Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem J (1989) 1.42
Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay. Clin Exp Immunol (1991) 1.39
3-Hydroxy-3-methylglutaryl coenzyme A reductase: regulation of enzymatic activity by phosphorylation and dephosphorylation. Proc Natl Acad Sci U S A (1978) 1.34
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J Exp Med (1988) 1.34
Immunofluorescence test for IgM rubella antibodies in whole serum after absorption with anti-gammaFc. Clin Exp Immunol (1975) 1.34
Purification and properties of a novel cytochrome: flavocytochrome c from Shewanella putrefaciens. Biochem J (1994) 1.33
The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis. J Exp Med (1979) 1.31
Enzyme immunoassay for detection of Giardia lamblia cyst antigens in formalin-fixed and unfixed human stool. J Clin Microbiol (1988) 1.31
Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol (1991) 1.31
C3d receptors are expressed on human monocytes after in vitro cultivation. Proc Natl Acad Sci U S A (1983) 1.30
Rapid diagnosis of vaginal candidosis by latex particle agglutination. J Clin Pathol (1985) 1.28
Human neutrophil adherence to laminin in vitro. Evidence for a distinct neutrophil integrin receptor for laminin. J Exp Med (1990) 1.27
Immunochemical analysis of cartilage proteoglycans. Radioimmunoassay of the molecules and the substructures. Biochem J (1980) 1.27
Isolation and characterization of cell surface mutants of Candida albicans. Infect Immun (1990) 1.27
Comparison of enzyme-linked immunosorbent assay and passive hemagglutination method for quantification of antibodies to lipopolysaccharide and tetanus toxoid in rats. Infect Immun (1979) 1.26
Immunoradiometric measurement of the factor VIII procoagulant antigen. J Clin Invest (1978) 1.21
Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest (1988) 1.20
Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule. Infect Immun (1998) 1.19
Intracellular localization of lipoxygenases-1 and -2 in germinating soybean seeds by indirect labeling with protein a-colloidal gold complexes. Plant Physiol (1984) 1.16
Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine. Gut (1990) 1.15
The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infect Immun (2002) 1.14
TCR3: a third T-cell receptor in the chicken. Proc Natl Acad Sci U S A (1989) 1.14
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis. Infect Immun (1997) 1.12
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest (1994) 1.11
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
Identification of a cysteine-rich receptor for fibroblast growth factors. Mol Cell Biol (1992) 1.10
Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin. Appl Environ Microbiol (1979) 1.09
Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15). Biochem J (1986) 1.09
Monoclonal antibody-based enzyme immunoassay for Giardia lamblia antigen in human stool. J Clin Microbiol (1989) 1.08
Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. J Clin Invest (1987) 1.08
Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine). Proc Natl Acad Sci U S A (1989) 1.05
Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. Proc Natl Acad Sci U S A (1991) 1.05
Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids. Infect Immun (1987) 0.99
Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products. Biochem J (1988) 0.98
Resolution and analysis of 'native' and 'activated' properdin. Biochem J (1987) 0.98
Antibodies to synthetic joining segment peptide of the T-cell receptor beta-chain: serological cross-reaction between products of T-cell receptor genes, antigen binding T-cell receptors, and immunoglobulins. Proc Natl Acad Sci U S A (1986) 0.97
Capsular sialic acid limits C5a production on type III group B streptococci. Infect Immun (1999) 0.97
Identification of acidic pH-dependent ligands of pentameric C-reactive protein. J Biol Chem (2010) 0.96
Immunofluorescence localization of thyroid hormone receptor protein beta 1 and variant alpha 2 in selected tissues: cerebellar Purkinje cells as a model for beta 1 receptor-mediated developmental effects of thyroid hormone in brain. Proc Natl Acad Sci U S A (1991) 0.96
Insulin and rabbit anti-insulin receptor antibodies stimulate additively the intrinsic receptor kinase activity. EMBO J (1987) 0.95
Uptake of cloacin DF13 by susceptible cells: removal of immunity protein and fragmentation of cloacin molecules. J Bacteriol (1986) 0.95
Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: a study of idiotypic determinants. Clin Exp Immunol (1979) 0.95
Avian erythrocyte agglutination tests with the sera of bird fanciers. J Clin Pathol (1977) 0.94
The relationship between neutrophils and increased microvascular permeability in a model of myocardial ischaemia and reperfusion in the rabbit. Br J Pharmacol (1990) 0.93
Evidence for the degradation of nicotinamide adenine dinucleotide phosphate-dependent glutamate dehydrogenase of Candida utilis during rapid enzyme inactivation. J Bacteriol (1978) 0.93
Detection of rubella virus-specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate. J Clin Microbiol (1999) 0.93
Production and characterization of monoclonal antibodies to Clostridium perfringens enterotoxin. Infect Immun (1986) 0.92
Apparent direct cellular cytotoxicity mediated via cytophilic antibody. Multiple Fc receptor bearing effector cell populations mediating cytophilic antibody induced cytotoxicity. Immunology (1977) 0.91
Characterization of a major antigenic component of Aspergillus fumigatus. Clin Exp Immunol (1986) 0.91
Estimation of amounts of anti-La(SS-B) antibody directed against immunodominant epitopes of the La(SS-B) autoantigen. Clin Exp Immunol (1991) 0.90
Role of fibronectin on the clearance and tissue uptake of antigen and immune complexes in rats. J Clin Invest (1987) 0.90
A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. Infect Immun (1993) 0.90
Diversity among Field Populations of Bradyrhizobium japonicum in Poland. Appl Environ Microbiol (1995) 0.90
Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. J Clin Invest (1977) 0.89
Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro. J Clin Invest (1983) 0.88
Immunochemical analysis of cartilage proteoglycans. Cross-reactivity of molecules isolated from different species. Biochem J (1981) 0.88
Synthesis and secretion of C-reactive protein by rabbit primary hepatocyte cultures. Biochem J (1983) 0.88
Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol (1993) 0.87
Paradoxical reconstitution of complement activity following plasma transfusion of an individual with deficiency of the seventh component of complement. Immunology (1994) 0.86
Experimental induction of rheumatoid factor and joint lesions in rabbits after intravenous injections of killed bacteria. Ann Rheum Dis (1986) 0.86
An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent. Clin Exp Immunol (1986) 0.86
Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies. Biochem J (1989) 0.86
Use of the enzyme-linked immunosorbent assay (ELISA) in immunotoxicity testing. Environ Health Perspect (1982) 0.85
Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells. J Clin Invest (1987) 0.85
A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned. Vaccine (2013) 0.85
A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus. J Clin Invest (1985) 0.84
In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations. Vox Sang (2012) 0.84
Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay. Infect Immun (1982) 0.84
Human alpha-lactalbumin as a marker of macromolecular absorption. Gut (1986) 0.84
Generation of chemotactic activity in serum by Haemophilus influenzae type b. Infect Immun (1984) 0.83
Clostridium difficile toxin A induces a specific antisecretory factor which protects against intestinal mucosal damage. Gut (1991) 0.83
Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved. Br J Pharmacol (1992) 0.83
Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors. Immunology (1988) 0.83
The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat. Clin Exp Immunol (1988) 0.83
Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies. Infect Immun (1992) 0.82
Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b. Immunology (1989) 0.82
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 2.40
Malignant neoplasms following bone marrow transplantation. Blood (1996) 1.76
Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr (1998) 1.65
Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int (2009) 1.63
Molecular alteration of alpha-2-macroglobulin by aliphatic amines. Biochim Biophys Acta (1968) 1.46
Liquid pasteurization of an immunoglobulin preparation without stabilizer: effects on its biological and biochemical properties. Vox Sang (1996) 1.42
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant (1999) 1.41
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells. Blood (1998) 1.39
RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia. Leukemia (2004) 1.38
Breast-feeding and risk of childhood acute leukemia. J Natl Cancer Inst (1999) 1.33
A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies. Eur J Immunol (2001) 1.15
A simple technique for the isolation of monoclonal IgG and IgA. Rev Eur Etud Clin Biol (1970) 1.14
Parental cigarette smoking and the risk of acute leukemia in children. Cancer (1999) 1.09
Molecular modification of ceruloplasmin by isoelectric focusing. Biochim Biophys Acta (1971) 1.04
Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c. Infect Immun (2009) 1.01
[Plasma protease inhibitors]. Rev Fr Transfus (1971) 0.99
The effect of laser radiations on human ceruloplasmin. Absorption, circular dichroism and electron paramagnetic resonance study. Biochem Biophys Res Commun (1978) 0.94
[Antiproteinase activity of alpha-2-macroglobulin. II. Its role in progressive antithrombin states]. Rev Fr Etud Clin Biol (1968) 0.93
Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res (1998) 0.92
The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK. Osteoporos Int (2009) 0.91
Alpha-2-macroglobulin as progressive antithrombin. Nature (1967) 0.90
Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy (2011) 0.90
[A new human serum polymorphism demonstration by the use of tanned erythrocytes adsorbing beta-1C globulin]. Bibl Haematol (1965) 0.89
Paternal military service and risk for childhood leukemia in offspring. Am J Epidemiol (2000) 0.89
Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine (1997) 0.89
Distribution of IgG subclasses in commercial and some experimental gamma-globulin preparations. Vox Sang (1977) 0.89
Cardiovascular function in children following bone marrow transplant: a cross-sectional study. Bone Marrow Transplant (1997) 0.88
Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood (1997) 0.87
MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine (1999) 0.87
Study on the plasmatic elimination of the alpha2-macroglobulin-proteinase complexes. Pathol Biol (Paris) (1973) 0.87
Spectroscopic and photoreduction studies of copper chromophores in ceruloplasmin. Eur J Biochem (1981) 0.87
The inter-alpha-trypsin inhibitor. Methods Enzymol (1976) 0.87
Pet ownership and childhood acute leukemia (USA and Canada). Cancer Causes Control (2001) 0.86
Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies. Parassitologia (1999) 0.86
In vitro, cell protective effects by certain antiproteases of human serum. Z Naturforsch B (1970) 0.84
Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood (1997) 0.83
Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. Transplantation (1994) 0.83
Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant (1996) 0.82
Ceruloplasmin-anicn interaction. A resonance Raman spectroscopic study. Biochem Biophys Res Commun (1975) 0.82
[Studies on monoclonal IgG. I. Isolation method based on the solubility of these proteins, and study, by electrophoresis in starch-urea gel, of reduction-alkylation products of these immunoglobulins]. Rev Fr Transfus (1970) 0.82
[Isolation of immunoglobulins gamma 1 and gamma 2 from goat, sheep and cattle plasmas]. C R Seances Soc Biol Fil (1970) 0.81
Study of the 2 macroglobulin-plasmin interaction mechanism. Pathol Biol (Paris) (1972) 0.81
Caprylic acid as an aid for the rapid isolation of human ceruloplasmin. Clin Chim Acta (1970) 0.81
[Studies on human alpha-2 macroglobulin structure and its complexes with proteases, using polyacrylamide gel electrophoresis]. Rev Fr Transfus Immunohematol (1975) 0.80
Accuracy of DNA amplification from archival hematological slides for use in genetic biomarker studies. Cancer Epidemiol Biomarkers Prev (1998) 0.80
[Isolation of IgG immunoglobulin from human plasma using caprylic acid]. Rev Fr Etud Clin Biol (1969) 0.80
[Preparation of alpha 2-macroglobulin as a by-product of fractionation]. Rev Fr Transfus (1970) 0.79
ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival. Ann Hematol (1997) 0.78
Ceruloplasmin-anion interaction. A circular dichroism spectroscopic study. Biochim Biophys Acta (1976) 0.78
[Calculation of the velocity coefficient (K) of the inactivation of complement by anticomplement substances]. Ann Inst Pasteur (Paris) (1966) 0.78
Properties of a new fibrin glue stable in liquid state. Thromb Res (1994) 0.78
Aprotinin is a competitive inhibitor of the factor VIIa-tissue factor complex. Thromb Res (1993) 0.78
Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purification. Thromb Res (1990) 0.77
The effects of neutral salts on the conformational transition of ceruloplasmin. Biochim Biophys Acta (1975) 0.77
Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF. Biol Blood Marrow Transplant (1997) 0.77
[Bactericidal and bacteriolytic immune reactions. Respective roles of complement and lysozyme. Their value in defense mechanisms against infection]. Rev Fr Transfus (1972) 0.77
Inhibition of plasmin by a small molecular weight inhibitor derived from human inter alpha trypsin inhibitor. Thromb Res (1978) 0.77
Interaction of alpha 2-macroglobulin-bound thrombin with hirudin. FEBS Lett (1984) 0.76
Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte--macrophage colony-stimulating factor. J Immunother (2001) 0.75
[Immunologic study of human gamma G globulins modified through the action of n-bromosuccinimide and cyanogen-bromide]. Bibl Haematol (1968) 0.75
Appraisal of the protein composition of prothrombin complex concentrates of different origins. Vox Sang (1987) 0.75
[Current concepts about complement]. Rev Eur Etud Clin Biol (1970) 0.75
[A human serum alpha-2-globulin of unusual lability: the pi protein]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.75
Study of different human and animal thromboplastins with human factor VIIa in the presence of aprotinin. Thromb Res (1994) 0.75
[Relations between the complement system and the kinin system]. Rev Fr Allergol (1972) 0.75
[Study of plasma clearance of ceruloplasmin and apoceruloplasmins in normal humans]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.75
Study of different human and animal thromboplastins with human factor VIIa in the presence of aprotinin. Thromb Res (1995) 0.75
[Use of the passive hemagglutination reaction in the study of serum groups of proteins]. Bibl Haematol (1968) 0.75
Optical boundary reconstruction of tokamak plasmas for feedback control of plasma position and shape. Rev Sci Instrum (2010) 0.75
[ Complement activation by the alternate pathway (or properdin pathway) in paroxysmal nocturnal hemoglobinuria]. Rev Fr Transfus (1974) 0.75
[Special preparation of intravenously injectable gamma globulin]. Presse Med (1969) 0.75
The preparation of gamma-globulin for intravenous use in Paris. Vox Sang (1967) 0.75
A human factor VIIa concentrate and its effects in the hemophilic A dog. Thromb Res (1989) 0.75
Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience. Int J Radiat Oncol Biol Phys (1996) 0.75
[Study of the anti-complement capacity of human plasma proteins. Action in vitro of ceruloplasmin]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.75
Sonographic findings in bone marrow transplant patients with symptomatic hepatic venoocclusive disease. J Ultrasound Med (1997) 0.75
[Obtainment of an enriched preparation of IgA and IgM immunoglobulins for therapeutic usage]. Dev Biol Stand (1974) 0.75
[Dissociation of the rheumatoid factor and the anti-Gm(a) activity of the serum in chronic evolutive polyarthritis]. Bibl Haematol (1965) 0.75
[Immunochemical study of the hemoglobin (erythrocruorine) of Arenicola marina L]. C R Seances Soc Biol Fil (1965) 0.75
[Determination of the Gm(a), Gm(b) and Bm(x) factors by use of SNagg (normal agglutinating sera) by a passive hemagglutination reaction]. Rev Fr Etud Clin Biol (1966) 0.75
The detection of Gm (a) specificity by passive hemagglutination using normal anti-Gm (a) serum (SNagg). Vox Sang (1966) 0.75
[Comparative immunologic study of antistreptokinase in preparations of IgG and IgA immunoglobulins]. Pathol Biol (1967) 0.75
Unusual activation mechanism of plasminogen. Thromb Res (1988) 0.75
[Method of isolation of orosomucoid from human plasma]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.75
Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study. Cephalalgia (1997) 0.75
[Study of the anticomplement power of human serum lipoproteins in vitro]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.75
[Electrophoretic behavior of human plasminogen on various media]. Rev Fr Transfus (1974) 0.75
Molecular support of rheumatoid factor and anti-Gm(a) activity. Nature (1965) 0.75
[Obtaining of antibodies (gamma 1 and gamma 2 immunoglobulins) from rabbit and horse plasma]. C R Seances Soc Biol Fil (1974) 0.75
[Study of the anticomplementary activity of human serum proteins]. Transfusion (Paris) (1967) 0.75
Preparation of an IgM and IgA enriched fraction for clinical use. Prep Biochem (1973) 0.75
Proteolytic digestion and chemical cleavage of human IgA. Prog Immunobiol Stand (1970) 0.75
[Papain digestion of normal human IgA. Physiochemical results]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.75